Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 371

1.

Knowledge and Opinions of Third Year Veterinary Students Relevant to Animal Welfare Before and After Implementation of a Core Welfare Course.

Johnstone ECS, Frye MA, Lord LK, Baysinger AK, Edwards-Callaway LN.

Front Vet Sci. 2019 Apr 10;6:103. doi: 10.3389/fvets.2019.00103. eCollection 2019.

2.

Predictors of psychotic symptoms among young people with special educational needs.

Stanfield AC, McKechanie AG, Lawrie SM, Johnstone EC, Owens DGC.

Br J Psychiatry. 2019 Jul;215(1):422-427. doi: 10.1192/bjp.2018.296. Epub 2019 Jan 29.

PMID:
30693855
3.

Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imaging.

Johnstone M, Vasistha NA, Barbu MC, Dando O, Burr K, Christopher E, Glen S, Robert C, Fetit R, Macleod KG, Livesey MR, Clair DS, Blackwood DHR, Millar K, Carragher NO, Hardingham GE, Wyllie DJA, Johnstone EC, Whalley HC, McIntosh AM, Lawrie SM, Chandran S.

Mol Psychiatry. 2019 Feb;24(2):294-311. doi: 10.1038/s41380-018-0292-1. Epub 2018 Nov 6.

4.

Is there a symptomatic distinction between the affective psychoses and schizophrenia? A machine learning approach.

Jauhar S, Krishnadas R, Nour MM, Cunningham-Owens D, Johnstone EC, Lawrie SM.

Schizophr Res. 2018 Dec;202:241-247. doi: 10.1016/j.schres.2018.06.070. Epub 2018 Jul 24.

PMID:
30054176
5.

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.

Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D, Kerr R, Sieber O, Taylor JC, Tomlinson I.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):635-643. doi: 10.1016/S2468-1253(18)30117-1. Epub 2018 Jul 2.

6.

The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.

Huijbers A, van Pelt GW, Kerr RS, Johnstone EC, Tollenaar RAEM, Kerr DJ, Mesker WE.

J Surg Oncol. 2018 Apr;117(5):1043-1048. doi: 10.1002/jso.24998. Epub 2018 Feb 15.

PMID:
29448309
7.

Dissociation of Brain Activation in Autism and Schizotypal Personality Disorder During Social Judgments.

Stanfield AC, Philip RCM, Whalley H, Romaniuk L, Hall J, Johnstone EC, Lawrie SM.

Schizophr Bull. 2017 Oct 21;43(6):1220-1228. doi: 10.1093/schbul/sbx083.

8.

Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.

Neilson E, Bois C, Clarke TK, Hall L, Johnstone EC, Owens DGC, Whalley HC, McIntosh AM, Lawrie SM.

Psychol Med. 2018 Jul;48(9):1532-1539. doi: 10.1017/S0033291717003087. Epub 2017 Oct 25.

10.

Links between Autism Spectrum Disorder Diagnostic Status and Family Quality of Life.

McKechanie AG, Moffat VJ, Johnstone EC, Fletcher-Watson S.

Children (Basel). 2017 Apr 3;4(4). pii: E23. doi: 10.3390/children4040023.

11.

Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features.

Zarogianni E, Storkey AJ, Johnstone EC, Owens DG, Lawrie SM.

Schizophr Res. 2017 Mar;181:6-12. doi: 10.1016/j.schres.2016.08.027. Epub 2016 Sep 6.

12.

Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.

Barker V, Bois C, Neilson E, Johnstone EC, Owens DGC, Whalley HC, McIntosh AM, Lawrie SM.

Schizophr Res. 2016 Aug;175(1-3):42-47. doi: 10.1016/j.schres.2016.04.028. Epub 2016 May 11.

PMID:
27179666
13.

Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia.

Barker V, Bois C, Johnstone EC, Owens DG, Whalley HC, McIntosh AM, Lawrie SM.

Psychol Med. 2016 Mar;46(4):891-6. doi: 10.1017/S0033291715002585. Epub 2015 Dec 14.

PMID:
26654172
14.

Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: preliminary findings from a 6-year follow-up study.

McKechanie AG, Moorhead TW, Stanfield AC, Whalley HC, Johnstone EC, Lawrie SM, Owens DG.

Br J Psychiatry. 2016 Jun;208(6):565-70. doi: 10.1192/bjp.bp.114.154526. Epub 2015 Dec 3.

PMID:
26635326
15.

Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis.

Stephan KE, Bach DR, Fletcher PC, Flint J, Frank MJ, Friston KJ, Heinz A, Huys QJM, Owen MJ, Binder EB, Dayan P, Johnstone EC, Meyer-Lindenberg A, Montague PR, Schnyder U, Wang XJ, Breakspear M.

Lancet Psychiatry. 2016 Jan;3(1):77-83. doi: 10.1016/S2215-0366(15)00361-2. Epub 2015 Nov 11. Review.

PMID:
26573970
16.

Charting the landscape of priority problems in psychiatry, part 2: pathogenesis and aetiology.

Stephan KE, Binder EB, Breakspear M, Dayan P, Johnstone EC, Meyer-Lindenberg A, Schnyder U, Wang XJ, Bach DR, Fletcher PC, Flint J, Frank MJ, Heinz A, Huys QJM, Montague PR, Owen MJ, Friston KJ.

Lancet Psychiatry. 2016 Jan;3(1):84-90. doi: 10.1016/S2215-0366(15)00360-0. Epub 2015 Nov 11. Review.

PMID:
26573969
17.

Grey matter networks in people at increased familial risk for schizophrenia.

Tijms BM, Sprooten E, Job D, Johnstone EC, Owens DG, Willshaw D, Seriès P, Lawrie SM.

Schizophr Res. 2015 Oct;168(1-2):1-8. doi: 10.1016/j.schres.2015.08.025. Epub 2015 Aug 30.

PMID:
26330380
18.

Brief Report: The Association of Autistic Traits and Behavioural Patterns in Adolescents Receiving Special Educational Assistance.

Paul AR, McKechanie AG, Johnstone EC, Owens DG, Stanfield AC.

J Autism Dev Disord. 2015 Sep;45(9):3055-60. doi: 10.1007/s10803-015-2445-2.

PMID:
25894524
19.

Hippocampal, amygdala and nucleus accumbens volume in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison.

Bois C, Levita L, Ripp I, Owens DC, Johnstone EC, Whalley HC, Lawrie SM.

Schizophr Res. 2015 Jun;165(1):45-51. doi: 10.1016/j.schres.2015.03.024. Epub 2015 Apr 10.

PMID:
25864953
20.

Cortical Surface Area Differentiates Familial High Risk Individuals Who Go on to Develop Schizophrenia.

Bois C, Ronan L, Levita L, Whalley HC, Giles S, McIntosh AM, Fletcher PC, Owens DC, Johnstone EC, Lawrie SM.

Biol Psychiatry. 2015 Sep 15;78(6):413-20. doi: 10.1016/j.biopsych.2014.12.030. Epub 2015 Feb 7.

21.

Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial.

McGregor MJ, Fadhil W, Wharton R, Yanagisawa Y, Presz M, Pritchard A, Womack C, Dutton S, Kerr RS, Kerr DJ, Johnstone EC, Ilyas M.

Anticancer Res. 2015 Mar;35(3):1641-5.

PMID:
25750322
22.

Longitudinal changes in hippocampal volume in the Edinburgh High Risk Study of Schizophrenia.

Bois C, Levita L, Ripp I, Owens DCG, Johnstone EC, Whalley HC, Lawrie SM.

Schizophr Res. 2016 Jun;173(3):146-151. doi: 10.1016/j.schres.2014.12.003. Epub 2014 Dec 19.

PMID:
25534070
23.

Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers.

Strong DR, David SP, Johnstone EC, Aveyard P, Murphy MF, Munafò MR.

Nicotine Tob Res. 2015 Jul;17(7):855-61. doi: 10.1093/ntr/ntu256. Epub 2014 Dec 6.

24.

Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium.

Taylor AE, Fluharty ME, Bjørngaard JH, Gabrielsen ME, Skorpen F, Marioni RE, Campbell A, Engmann J, Mirza SS, Loukola A, Laatikainen T, Partonen T, Kaakinen M, Ducci F, Cavadino A, Husemoen LLN, Ahluwalia TS, Jacobsen RK, Skaaby T, Ebstrup JF, Mortensen EL, Minica CC, Vink JM, Willemsen G, Marques-Vidal P, Dale CE, Amuzu A, Lennon LT, Lahti J, Palotie A, Räikkönen K, Wong A, Paternoster L, Wong AP, Horwood LJ, Murphy M, Johnstone EC, Kennedy MA, Pausova Z, Paus T, Ben-Shlomo Y, Nohr EA, Kuh D, Kivimaki M, Eriksson JG, Morris RW, Casas JP, Preisig M, Boomsma DI, Linneberg A, Power C, Hyppönen E, Veijola J, Jarvelin MR, Korhonen T, Tiemeier H, Kumari M, Porteous DJ, Hayward C, Romundstad PR, Smith GD, Munafò MR.

BMJ Open. 2014 Oct 7;4(10):e006141. doi: 10.1136/bmjopen-2014-006141.

25.

Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder.

Dauvermann MR, Whalley HC, Schmidt A, Lee GL, Romaniuk L, Roberts N, Johnstone EC, Lawrie SM, Moorhead TW.

Front Psychiatry. 2014 Mar 25;5:30. doi: 10.3389/fpsyt.2014.00030. eCollection 2014. Review.

26.

Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison.

Sprooten E, Papmeyer M, Smyth AM, Vincenz D, Honold S, Conlon GA, Moorhead TW, Job D, Whalley HC, Hall J, McIntosh AM, Owens DC, Johnstone EC, Lawrie SM.

Schizophr Res. 2013 Dec;151(1-3):259-64. doi: 10.1016/j.schres.2013.09.024. Epub 2013 Oct 10.

PMID:
24120958
27.

The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia.

Dauvermann MR, Whalley HC, Romaniuk L, Valton V, Owens DG, Johnstone EC, Lawrie SM, Moorhead TW.

Neuroimage. 2013 Jun;73:16-29. doi: 10.1016/j.neuroimage.2013.01.063. Epub 2013 Feb 4.

PMID:
23384525
28.

Longitudinal gray matter change in young people who are at enhanced risk of schizophrenia due to intellectual impairment.

Moorhead TW, Stanfield AC, McKechanie AG, Dauvermann MR, Johnstone EC, Lawrie SM, Cunningham Owens DG.

Biol Psychiatry. 2013 May 15;73(10):985-92. doi: 10.1016/j.biopsych.2012.12.011. Epub 2013 Jan 17.

PMID:
23332356
29.

Social cognition, the male brain and the autism spectrum.

Hall J, Philip RC, Marwick K, Whalley HC, Romaniuk L, McIntosh AM, Santos I, Sprengelmeyer R, Johnstone EC, Stanfield AC, Young AW, Lawrie SM.

PLoS One. 2012;7(12):e49033. doi: 10.1371/journal.pone.0049033. Epub 2012 Dec 26.

30.

Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia.

Welch KA, Moorhead TW, McIntosh AM, Owens DG, Johnstone EC, Lawrie SM.

Psychol Med. 2013 Oct;43(10):2087-96. doi: 10.1017/S0033291712002668. Epub 2012 Nov 29.

PMID:
23190458
31.

Lack of association of OPRM1 genotype and smoking cessation.

Munafò MR, Johnstone EC, Aveyard P, Marteau T.

Nicotine Tob Res. 2013 Mar;15(3):739-44. doi: 10.1093/ntr/nts174. Epub 2012 Sep 18.

PMID:
22990223
32.

Predicting first episode psychosis in those at high risk for genetic or cognitive reasons.

Lawrie SM, Stanfield A, Johnstone EC, McIntosh AM.

Epidemiol Psychiatr Sci. 2012 Dec;21(4):323-8. doi: 10.1017/S2045796012000509. Epub 2012 Sep 12.

PMID:
22967956
33.

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

Huijbers A, Tollenaar RA, v Pelt GW, Zeestraten EC, Dutton S, McConkey CC, Domingo E, Smit VT, Midgley R, Warren BF, Johnstone EC, Kerr DJ, Mesker WE.

Ann Oncol. 2013 Jan;24(1):179-85. doi: 10.1093/annonc/mds246. Epub 2012 Aug 2.

PMID:
22865778
34.

Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder.

Whalley HC, Papmeyer M, Romaniuk L, Sprooten E, Johnstone EC, Hall J, Lawrie SM, Evans KL, Blumberg HP, Sussmann JE, McIntosh AM.

Neuropsychopharmacology. 2012 Nov;37(12):2720-9. doi: 10.1038/npp.2012.137. Epub 2012 Aug 1.

35.

Evaluation of a screening instrument for autism spectrum disorders in prisoners.

Robinson L, Spencer MD, Thomson LD, Stanfield AC, Owens DG, Hall J, Johnstone EC.

PLoS One. 2012;7(5):e36078. doi: 10.1371/journal.pone.0036078. Epub 2012 May 25.

36.

Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure.

Munafò MR, Timofeeva MN, Morris RW, Prieto-Merino D, Sattar N, Brennan P, Johnstone EC, Relton C, Johnson PC, Walther D, Whincup PH, Casas JP, Uhl GR, Vineis P, Padmanabhan S, Jefferis BJ, Amuzu A, Riboli E, Upton MN, Aveyard P, Ebrahim S, Hingorani AD, Watt G, Palmer TM, Timpson NJ; EPIC Study Group, Davey Smith G.

J Natl Cancer Inst. 2012 May 16;104(10):740-8. doi: 10.1093/jnci/djs191. Epub 2012 Apr 25.

37.

Anterior cingulate morphology in people at genetic high-risk of schizophrenia.

Meredith SM, Whyler NC, Stanfield AC, Chakirova G, Moorhead TW, Job DE, Giles S, McIntosh AM, Johnstone EC, Lawrie SM.

Eur Psychiatry. 2012 Jul;27(5):377-85. doi: 10.1016/j.eurpsy.2011.11.004. Epub 2012 Apr 17.

PMID:
22512930
38.

Use of second-person pronouns and schizophrenia.

Watson AR, Defterali C, Bak TH, Sorace A, McIntosh AM, Owens DG, Johnstone EC, Lawrie SM.

Br J Psychiatry. 2012 Apr;200(4):342-3. doi: 10.1192/bjp.bp.111.095448. Epub 2012 Mar 8.

PMID:
22403087
39.

Determinants of adult functional outcome in adolescents receiving special educational assistance.

McGeown HR, Johnstone EC, McKirdy J, Owens DC, Stanfield AC.

J Intellect Disabil Res. 2013 Aug;57(8):766-33. doi: 10.1111/j.1365-2788.2011.01533.x. Epub 2012 Feb 28.

PMID:
22369675
40.

Effects of a mis-sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia.

Whalley HC, Sussmann JE, Johnstone M, Romaniuk L, Redpath H, Chakirova G, Mukherjee P, Hall J, Johnstone EC, Lawrie SM, McIntosh AM.

Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):343-53. doi: 10.1002/ajmg.b.32035. Epub 2012 Feb 15.

PMID:
22337479
41.

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.

Spruell T, Colavita G, Donegan T, Egawhary M, Hurley M, Aveyard P, Johnstone EC, Murphy MF, Munafò MR.

Nicotine Tob Res. 2012 Aug;14(8):993-7. doi: 10.1093/ntr/ntr246. Epub 2011 Dec 17.

PMID:
22180580
42.

Facial emotion recognition in Scottish prisoners.

Robinson L, Spencer MD, Thomson LD, Sprengelmeyer R, Owens DG, Stanfield AC, Hall J, Baig BJ, MacIntyre DJ, McKechanie A, Johnstone EC.

Int J Law Psychiatry. 2012 Jan-Feb;35(1):57-61. doi: 10.1016/j.ijlp.2011.11.009. Epub 2011 Dec 6.

PMID:
22153834
43.

Effect of variation in diacylglycerol kinase η (DGKH) gene on brain function in a cohort at familial risk of bipolar disorder.

Whalley HC, Papmeyer M, Romaniuk L, Johnstone EC, Hall J, Lawrie SM, Sussmann JE, McIntosh AM.

Neuropsychopharmacology. 2012 Mar;37(4):919-28. doi: 10.1038/npp.2011.272. Epub 2011 Nov 2.

44.

Lower effective connectivity between amygdala and parietal regions in response to fearful faces in schizophrenia.

Mukherjee P, Whalley HC, McKirdy JW, McIntosh AM, Johnstone EC, Lawrie SM, Hall J.

Schizophr Res. 2012 Feb;134(2-3):118-24. doi: 10.1016/j.schres.2011.09.033. Epub 2011 Oct 22.

PMID:
22019361
45.

Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals.

Whalley HC, O'Connell G, Sussmann JE, Peel A, Stanfield AC, Hayiou-Thomas ME, Johnstone EC, Lawrie SM, McIntosh AM, Hall J.

Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(8):941-8. doi: 10.1002/ajmg.b.31241. Epub 2011 Oct 10.

PMID:
21987501
46.

Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.

Welch KA, Stanfield AC, McIntosh AM, Whalley HC, Job DE, Moorhead TW, Owens DG, Lawrie SM, Johnstone EC.

Br J Psychiatry. 2011 Nov;199(5):386-90. doi: 10.1192/bjp.bp.110.090175. Epub 2011 Sep 8.

PMID:
21903664
47.

CHRNA3 rs1051730 genotype and short-term smoking cessation.

Munafò MR, Johnstone EC, Walther D, Uhl GR, Murphy MF, Aveyard P.

Nicotine Tob Res. 2011 Oct;13(10):982-8. doi: 10.1093/ntr/ntr106. Epub 2011 Jun 20.

48.

The neural basis of familial risk and temperamental variation in individuals at high risk of bipolar disorder.

Whalley HC, Sussmann JE, Chakirova G, Mukerjee P, Peel A, McKirdy J, Hall J, Johnstone EC, Lawrie SM, McIntosh AM.

Biol Psychiatry. 2011 Aug 15;70(4):343-9. doi: 10.1016/j.biopsych.2011.04.007. Epub 2011 May 24.

PMID:
21601834
49.

White matter integrity in individuals at high genetic risk of bipolar disorder.

Sprooten E, Sussmann JE, Clugston A, Peel A, McKirdy J, Moorhead TW, Anderson S, Shand AJ, Giles S, Bastin ME, Hall J, Johnstone EC, Lawrie SM, McIntosh AM.

Biol Psychiatry. 2011 Aug 15;70(4):350-6. doi: 10.1016/j.biopsych.2011.01.021. Epub 2011 Mar 23.

PMID:
21429475
50.

The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.

Chakirova G, Whalley HC, Thomson PA, Hennah W, Moorhead TW, Welch KA, Giles S, Hall J, Johnstone EC, Lawrie SM, Porteous DJ, Brown VJ, McIntosh AM.

Psychiatry Res. 2011 Apr 30;192(1):20-8. doi: 10.1016/j.pscychresns.2011.01.015. Epub 2011 Mar 3.

PMID:
21376542

Supplemental Content

Loading ...
Support Center